European HIV/AIDS Therapeutics Markets

European HIV/AIDS Therapeutics Markets published by Frost & Sullivan in April, 2009. This report consists of 59 Pages and the price starts from US $ 6500.

Introduction

Abstract

This research service analyses the rapidly evolving European HIV/AIDS therapeutic market. The research service provides revenue estimation and forecast based on the factors that are expected drive and restrain the market in the forecast period. Challenges faced by the industry are analysed and strategic recommendations are discussed based on the current and future trends in the European market.

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary for the European HIV/AIDS Therapeutics Market

• Summary

2. GLOSSARY

Glossary of Terms

• Key Words and Acronyms

3. RESEARCH METHODOLOGY

Research Methodology for the European HIV/AIDS Therapeutics Market

• Research Methodology and Segmentation

4. INDUSTRY CHALLENGES

Challenges Facing the European HIV/AIDS Industry

• Challenges

5. EUROPEAN HIV/AIDS THERAPEUTICS MARKET OUTLOOK

Introduction

• Disease Description
• Treatment Options
• Epidemiology

Country Overview

• France
• Germany
• Italy
• Spain
• The United Kingdom

6. MARKET ENGINEERING RESEARCH FOR THE EUROPEAN HIV/AIDS THERAPEUTICS MARKET

European HIV/AIDS Therapeutics Market

• Introduction
• Market Engineering Measurements
• Market Drivers
• Market Restraints
• Revenue Forecasts

7. COMPETITOR ANALYSIS

Competitor Profiles

• Competitive Analysis
• Profiles

8. STRATEGIC RECOMMENDATIONS

Strategic Recommendations for the Market Participants

• Recommendations

9. DECISION SUPPORT DATABASES

Decision Support Databases

• Total Healthcare Expenditure
• Pharmaceutical R&D Expenditure
• Total Population
• Birth Rates
• Mortality Rates

Related Reports